v3.25.4
ACQUISITIONS AND LICENSING AGREEMENTS - 2023 Acquisitions, Narrative (Details)
 1 Months Ended 3 Months Ended 12 Months Ended 35 Months Ended
Sep. 29, 2023
USD ($)
rate
Jul. 06, 2023
USD ($)
Jan. 17, 2023
USD ($)
Jan. 31, 2023
USD ($)
Dec. 31, 2023
USD ($)
Dec. 31, 2025
USD ($)
Dec. 31, 2024
USD ($)
Dec. 31, 2023
USD ($)
Dec. 31, 2025
USD ($)
Dec. 31, 2022
USD ($)
Asset Acquisition And Business Combination [Line Items]                    
Fair value, contingent consideration liability           $ 96,000,000 $ 123,000,000   $ 96,000,000  
Other expense, net           75,000,000 44,000,000 $ 74,000,000    
Interest expense, net           421,000,000 399,000,000 283,000,000    
Goodwill         $ 4,575,000,000 $ 4,758,000,000 4,523,000,000 4,575,000,000 4,758,000,000 $ 4,507,000,000
Johnson & Johnson Vision, Blink Product Line Acquisition                    
Asset Acquisition And Business Combination [Line Items]                    
Payment to acquire business, asset acquisition   $ 107,000,000                
XIIDRA Acquisition                    
Asset Acquisition And Business Combination [Line Items]                    
Cash consideration paid $ 1,750,000,000                  
Potential future milestone obligation (up to) 750,000,000                  
Fair value, contingent consideration liability $ 3,000,000                  
Measurement period adjustment, intangible assets, net         5,000,000          
Measurement period adjustment, prepaid expenses and other current assets         5,000,000          
Inventory release turnover cycle, favorable contract, term 2 years                  
Inventory released to cost of goods sold             $ 81,000,000 20,000,000    
Revenues since acquisition         106,000,000          
Earnings since acquisition         $ 17,000,000          
Aggregate purchase consideration $ 1,753,000,000                  
Prepaid expenses and other current assets 162,000,000                  
Goodwill 23,000,000                  
Accrued and other current liabilities 1,000,000                  
XIIDRA Acquisition | Acquisition-Related Transaction Costs                    
Asset Acquisition And Business Combination [Line Items]                    
Other expense, net               20,000,000    
XIIDRA Acquisition | Acquisition-Related Finance Costs                    
Asset Acquisition And Business Combination [Line Items]                    
Interest expense, net               $ 16,000,000    
XIIDRA Acquisition | Cash Payable Upon the Achievement of Specified Commercialization and Sales Milestones for Certain Pipeline Products                    
Asset Acquisition And Business Combination [Line Items]                    
Potential future milestone obligation (up to) 475,000,000                  
XIIDRA Acquisition | Cash Payable Upon the Achievement of Specified Sales Milestones                    
Asset Acquisition And Business Combination [Line Items]                    
Potential future milestone obligation (up to) 275,000,000                  
XIIDRA Acquisition | Sales-Based Milestone Payments                    
Asset Acquisition And Business Combination [Line Items]                    
Fair value, contingent consideration liability $ 31,000,000                  
XIIDRA Acquisition | Sales-Based Milestone Payments | Measurement Input, Discount Rate                    
Asset Acquisition And Business Combination [Line Items]                    
Fair value, contingent consideration liability, discount rate | rate 0.11                  
AcuFocus, Inc. Acquisition                    
Asset Acquisition And Business Combination [Line Items]                    
Cash consideration paid       $ 31,000,000            
Fair value, contingent consideration liability     $ 5,000,000              
Aggregate purchase consideration     $ 35,000,000              
Purchase price, repayment term     18 months              
Inventories, net     $ 4,000,000              
Prepaid expenses and other current assets     4,000,000              
Intangibles, net     28,000,000              
Goodwill     2,000,000              
Deferred tax assets, net     2,000,000              
Property, plant and equipment, net     1,000,000              
Accounts payable     1,000,000              
Accrued and other current liabilities     $ 1,000,000              
Measurement period adjustments, deferred tax assets                 6,000,000  
Measurement period adjustments, goodwill                 $ 6,000,000